Evaluation of AYA22T-aptamer at different concentrations revealed their efficacy in inducing CTL-mediated lysis of specific tumor cells, particularly BT-549 (ER-/PR-/HER2-) (Supplementary Materials, Figure S9A), when compared to control aptamers or no treatment. The gene discussed is ERBB2; the disease is neoplasm.